3-[1-(4-ethylsulfonylpiperazin-1-yl)-4,4-difluorocyclohexyl]-1-(2,4,6-trimethylphenyl)propan-1-one
C24H36F2N2O3S — CID 58561946
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[1-(4-ethylsulfonylpiperazin-1-yl)-4,4-difluorocyclohexyl]-1-(2,4,6-trimethylphenyl)propan-1-one
3-[1-(4-ethylsulfonylpiperazin-1-yl)-4,4-difluorocyclohexyl]-1-(2,4,6-trimethylphenyl)propan-1-one (PubChem CID 58561946) has the molecular formula C24H36F2N2O3S and a molecular weight of 470.63 g/mol. Its IUPAC name is 3-[1-(4-ethylsulfonylpiperazin-1-yl)-4,4-difluorocyclohexyl]-1-(2,4,6-trimethylphenyl)propan-1-one.
Molecular Properties
| Compound Name | 3-[1-(4-ethylsulfonylpiperazin-1-yl)-4,4-difluorocyclohexyl]-1-(2,4,6-trimethylphenyl)propan-1-one |
|---|---|
| PubChem CID | 58561946 |
| Molecular Formula | C24H36F2N2O3S |
| Molecular Weight | 470.63 g/mol |
| Exact Mass | 470.24 |
| IUPAC Name | 3-[1-(4-ethylsulfonylpiperazin-1-yl)-4,4-difluorocyclohexyl]-1-(2,4,6-trimethylphenyl)propan-1-one |
| SMILES | CCS(=O)(=O)N1CCN(C2(CCC(=O)c3c(C)cc(C)cc3C)CCC(F)(F)CC2)CC1 |
| InChI | InChI=1S/C24H36F2N2O3S/c1-5-32(30,31)28-14-12-27(13-15-28)23(8-10-24(25,26)11-9-23)7-6-21(29)22-19(3)16-18(2)17-20(22)4/h16-17H,5-15H2,1-4H3 |
| InChIKey | HUDIYDGRQBRSMI-UHFFFAOYSA-N |
| XLogP | 4.49 |
| TPSA | 57.69 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.63 |
| LogP ≤ 5 | 4.49 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58561946 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.